ArticleScientific reports2024
Expansion of thyroid surgical territory through 10,000 cases under the da Vinci robotic knife.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 14 citations in OpenAlex.
- Perioperative and oncologic outcomes of 1,000 consecutive single-port transaxillary robotic thyroidectomy (SP-TART).Surgical endoscopy · 2026Article
- Locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer: long-term outcomes in 10,504 patients.Surgical endoscopy · 2026Article
- Not all patients need a robot: comparative perioperative outcomes of robotic BABA versus endoscopic CABBA thyroid lobectomy with ipsilateral central lymph node dissection, stratified by body mass index.Journal of robotic surgery · 2026Article
- Robotic thyroidectomy using the da Vinci SP surgical system.Surgical endoscopy · 2026Review
- Transaxillary Robotic Thyroidectomy: A Novel Technique and Update.Journal of clinical medicine · 2026Review
- Comparison of the application value of bipolar electrocoagulation and ultrasonic scalpel in robot-assisted thyroid carcinoma surgery: a single-center study based on perioperative indicator and short-term prognosis.Frontiers in surgery · 2026Article
- Recent advances in single-port robotic thyroidectomy: evolution, techniques, and clinical outcomes.Annals of surgical treatment and research · 2026Review
- [Current application and future development trends of robotic head and neck surgery].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025Review
- The Integration of Artificial Intelligence into Robotic Cancer Surgery: A Systematic Review.Journal of clinical medicine · 2025Review
- The evolution and clinical impact of single-port transaxillary robotic thyroidectomy: a comprehensive review.Gland surgery · 2025Review
- One-Year Clinical Experience of Single-Port and Multi-Port Robotic Thyroid Surgery in a Single Institution.Journal of clinical medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the progress of robotic transaxillary thyroid surgery (RTTS), the indications for this procedure have gradually expanded. This study presents the insights gained from performing 10,000 RTTS cases at a single institution, along with the expansion of indications over time. RTTS was performed on 10,000 patients using the da Vinci robot system between October 2007 and April 2023 at the Yonsei University Health System, Seoul, Korea. Among 10,000 patients, 9461 (94.0%) were diagnosed with thyroid cancer, whereas 539 (5.4%) had either a benign thyroid nodule or Graves' disease. Surgical procedures were performed using four-arm-based robots (da Vinci S, Si, or Xi) for 8408 cases (84.1%), with the remaining 1592 cases (15.9%) being performed using the da Vinci SP surgical robotic system. Notably, for 53 patients with nodules ≥ 5 cm, which were not included in the eligibility criteria of the previous study, RTTS was performed safely without significant complications. The most common postoperative complication was transient hypoparathyroidism (37.91%), and recurrence occurred in 100 patients with thyroid cancer (1.1%). In conclusion, RTTS appears safe and feasible from both surgical and oncological perspectives, and the spectrum of indications suitable for RTTS surgery is progressively expanding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.